Compare SSTI & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SSTI | XBIT |
|---|---|---|
| Founded | 1996 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Pharmaceuticals and Biotechnology |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.3M | 71.3M |
| IPO Year | 2017 | 2015 |
| Metric | SSTI | XBIT |
|---|---|---|
| Price | $6.71 | $2.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 166.6K | 44.2K |
| Earning Date | 03-03-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $34,753,000.00 | N/A |
| Revenue This Year | $11.93 | N/A |
| Revenue Next Year | $9.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 46.25 | N/A |
| 52 Week Low | $5.78 | $2.09 |
| 52 Week High | $17.38 | $3.62 |
| Indicator | SSTI | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 46.09 | 51.24 |
| Support Level | $6.03 | $2.32 |
| Resistance Level | $7.96 | $2.49 |
| Average True Range (ATR) | 0.49 | 0.10 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 39.29 | 61.90 |
SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes ShotSpotter, the acoustic gunshot detection system, CrimeTracer, the foremost law enforcement search engine, CaseBuilder, a one-stop investigation management system, and ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.